Brief: Sienna Biopharmaceuticals files for Chapter 11 bankruptcy, seeks buyer or partner

Sienna Biopharmaceuticals

17/09/2019 13:16

Sept 17 (Reuters) - Sienna biopharmaceuticals  SNNA.O  files
for chapter 11 bankruptcy protection in delaware, two years
after going public -- court filing
Sienna ceo cites lack of viable financing options, dwindling
liquidity and overhang of milestone payments as reasons for
chapter 11 filing
Sienna ceo says the company has retained cowen and co to
evaluate its options, and believes it will be successful in
finding a purchaser or strategic partner soon
Sienna says it had $107.6 million of assets, $80.6 million of
debts as of june 30 -- bankruptcy petition